Skip to content
Recall Observatory FDA recall evidence

Drug product

Lamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual Dose NDC: 60687-362-11), Distributed by American Health Packaging, Columbus, OH

D-1847-2019

August 27, 2019

Class III

Product summary

Firm
American Health Packaging
Event
Event 83672
Status
Terminated
Classification
Class III
Quantity
60 cartons
Official record key
drug-enforcement:D-1847-2019

Official wording

Reason: Labeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for the tablets.

Code information: Lots 186509 and 186982, exp 6/30/2021

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Incorrect or Missing